Location: United States
Total raised: $30M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.04.2026 | Series C | $30M | Crescent E... |
Mentions in press and media 6
| Date | Title | Description |
| 23.04.2026 | Houston geothermal unicorn Fervo officially files for IPO | Fervo Energy has officially filed for IPO. The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange.... |
| 23.04.2026 | Houston medtech firm secures $30M for neurosurgical robot | Robotic neurosurgery is an exciting new frontier in medicine, and Houston-based medtech firm XCath is leading the charge with its revolutionary Iris robotic system. The company announced in March that it had secured $30 million in Series C ... |
| 13.03.2026 | XCath Secures $30 Million to Revolutionize Neuro-Endovascular Robotics | XCath secured $30 million in Series C funding. This boosts its neuro-endovascular surgical robotics development. The Iris system targets complex brain aneurysms and stroke treatment. It uniquely achieves intracranial navigation. This innova... |
| 12.03.2026 | XCath: $30 Million Raised For Neuro-Endovascular Surgical Robotics Development | XCath, a medical device company developing robotic technology for neuro-endovascular procedures, has secured $30 million in Series C funding to advance development and commercialization of its endovascular surgical robot. The round was co-l... |
| 12.03.2026 | XCath Raises $30M in Series C Funding | XCath, a Houston, TX-based medical device company developing neuro-endovascular surgical robotics, raised $30M in Series C funding. The round was led by Crescent Enterprises and by Dr. Fred Moll. The raise brought the total amount to $92M. ... |
| - | XCath | “XCath develops next-generation endovascular robotics and steerable neurovascular guidewires for precision navigation in complex vascular procedures.” |